Foyston Gordon & Payne Inc reduced its position in shares of Sanofi (NASDAQ:SNY – Get Rating) by 6.3% during the fourth quarter, according to the company in its most recent 13F filing with the SEC. The firm owned 48,456 shares of the company’s stock after selling 3,233 shares during the quarter. Foyston Gordon & Payne […]